Skip to main content
Log in

Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT)

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To verify whether carriers of common single-nucleotide polymorphisms (SNPs) of the FSH receptor (FSHR) show reduced responsiveness of antral follicles to FSH administration as assessed by the FORT.

Methods

We performed a prospective study in a university hospital. Study population consisted of 124 Caucasian IVF-ET candidates. FSHR 307Ala and 680Ser variants were analyzed in haplotypes and as separated genes. Serum FSH, estradiol (E2), and anti-Müllerian hormone (AMH) were measured on cycle-day 3. Antral follicle (3–8 mm) count (AFC) and preovulatory follicle (16–22 mm) count (PFC) were performed, respectively, at the achievement of pituitary suppression (before FSH administration) and on the day of hCG administration. Antral follicle responsiveness to FSH administration assessed by the FORT (PFCx100/AFC).

Results

Data concerning baseline and IVF-ET parameters were similar between SNPs carriers and controls. Moreover, FORT was similar for different haplotypes Thr307-Asn680 (45.9%) and Ala307-Ser680 (39.4%) and 307Thr/Ala-Ala/Ala (41.1%; 5.0–91.6%) versus 307Thr/Thr (44.4%; 17.3–83.3%) and in 680Asn/Ser-Ser/Ser (40.0%; 5.0–91.6%) versus 680Asn/Asn (42.2%; 8.3–90.0%) carriers.

Conclusions

Antral follicle responsiveness to FSH, as far as measured by the FORT, is not influenced by the presence of SNPs of FSHR 307Ala and 680Ser.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959–68.

    Article  PubMed  CAS  Google Scholar 

  2. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15(7):451–6.

    Article  PubMed  CAS  Google Scholar 

  3. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89(12):6310–5. doi:10.1210/jc.2004-1044.

    Article  PubMed  CAS  Google Scholar 

  4. de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, Real LM, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003;80(3):571–6.

    Article  PubMed  Google Scholar 

  5. Fanchin R, Schonauer LM, Cunha-Filho JS, Mendez Lozano DH, Frydman R. Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation. Semin Reprod Med. 2005;23(4):354–62. doi:10.1055/s-2005-923393.

    Article  PubMed  CAS  Google Scholar 

  6. Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26(3):671–7. doi:10.1093/humrep/deq361.

    Article  PubMed  CAS  Google Scholar 

  7. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab. 2005;90(8):4866–72. doi:10.1210/jc.2004-2268.

    Article  PubMed  CAS  Google Scholar 

  8. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83(2):291–301. doi:10.1016/j.fertnstert.2004.10.011.

    Article  PubMed  Google Scholar 

  9. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006;13(5):687–95.

    Article  PubMed  CAS  Google Scholar 

  10. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol. 2009;62(6):597–608. doi:10.1016/j.jclinepi.2008.12.004. e594.

    Article  PubMed  Google Scholar 

  11. Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod. 2009;24(8):2007–13. doi:10.1093/humrep/dep114.

    Article  PubMed  CAS  Google Scholar 

  12. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85(9):3365–9.

    Article  PubMed  CAS  Google Scholar 

  13. Rodini GP, Genro VK, Matte U, Pereira FS, Bilibio JP, Greggianin C, et al. There is no complete linkage between the polymorphisms N680S and T307A of the follicular stimulating hormone receptor gene in fertile women. J Assist Reprod Genet. 2011;28(3):221–4. doi:10.1007/s10815-010-9503-7.

    Article  PubMed  Google Scholar 

  14. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab. 1999;84(2):751–5.

    Article  PubMed  CAS  Google Scholar 

  15. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002;8(10):893–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Financial support

This study was supported by a scholarship from the CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) and a grant from the Fundo de Incentivo a Pesquisa (FIPE) of Hospital de Clínicas de Porto Alegre—RS—Brazil.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vanessa Krebs Genro.

Additional information

Capsule

FSH receptor genotype does not influence antral follicle responsiveness to exogenous gonadotropin as far as measured by FORT.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Genro, V.K., Matte, U., De Conto, E. et al. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT). J Assist Reprod Genet 29, 657–663 (2012). https://doi.org/10.1007/s10815-012-9761-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9761-7

Keywords

Navigation